Diagnostic testing kits maker Immunodiagnostic Systems has reported a £4m rise in revenue for the year to 31 August.

Chairman, David Evans, said: "Revenues to 31 August are £22.6m compared with £18.4m for the comparative period in 2010. As of 31 August 299 instruments have been sold or placed an increase of 58 systems since the year end and we anticipate a further 15 instruments being placed or sold in September. Average revenue per instrument is £88k compared to £72k in August 2010.

"Our revenues are traditionally weighted to the second-half of the year and we believe this year that the trend ratio will be higher this financial year reflecting both a seasonally quieter July and August and also higher anticipated reagent / instrument sales pull-through and the anticipated continued resilience of manual product sales in the second-half."

The share price was down 5.27% to 1,042.00p at 14:10.

NR

Related share prices
Immunodiagnostic Systems Holdings (IDH) share price